• 1.

    Klaphake E, Gibbons PM, Sladky KK, et al. Reptiles. In: Carpenter CW, Marion CJ, eds. Exotic animal formulary. 5th ed. St Louis: Elsevier, 2018;124125.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 2.

    Goe AM, Heard DJ, Abbott JR, et al. Surgical management of an odontogenic tumor in a banded Gila monster (Heloderma suspectum cinctum) with a novel herpesvirus. Vet Q 2016;36:109114.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 3.

    VanDevanter DR, Warrener P, Bennett L, et al. Detection and analysis of diverse herpesviral species by consensus primer PCR. J Clin Microbiol 1996;34:16661671.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4.

    Hannon DE, Garner MM, Reavill DR. Squamous cell carcinomas in inland bearded dragons (Pogona vitticeps). J Herpetological Med Surg 2011;21:101106.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5.

    Jankowski G, Sirninger J, Borne J, et al. Chemotherapeutic treatment for leukemia in a bearded dragon (Pogona vitticeps). J Zoo Wildl Med 2011;42:322325.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6.

    Gardhouse S, Eshar D, Lee-Chow B, et al. Diagnosis and treatment of a periocular myxosarcoma in a bearded dragon (Pogona vitticeps). Can Vet J 2014;55:663666.

    • Search Google Scholar
    • Export Citation
  • 7.

    Darrow BG, Johnstone McLean NS, Russman SE, et al. Periorbital adenocarcinoma in a bearded dragon (Pogona vitticeps). Vet Ophthalmol 2013;16:177182.

  • 8.

    Jakab C, Miklos R, Zoltan S, et al. Claudin-7-positive synchronous spontaneous intrahepatic cholangiocarcinoma, adenocarcinoma and adenomas of the gallbladder in a bearded dragon (Pogona vitticeps). Acta Vet Hung 2011;59:99112.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9.

    Ritter JM, Garner MM, Chilton ER, et al. Gastric neuroendocrine carcinomas in bearded dragons (Pogona vitticeps). Vet Pathol 2009;46:11091116.

  • 10.

    Suedmeyer WK, Turk J. Lymphoblastic leukemia in an inland bearded dragon (Pogona vitticeps). Bull Assoc Reptil Amphib Vet 1996;6:1012.

    • Search Google Scholar
    • Export Citation
  • 11.

    Tocidlowski ME, McNamara PL, Wojcieszyn JW. Myelogenous leukemia in a bearded dragon (Acanthodraco vitticeps). J Zoo Wildl Med 2001;32:9095.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 12.

    Gregory CR, Latimer KS, Fontenot DK, et al. Chronic monocytic leukemia in an inland bearded dragon, Pogona vitticeps. J Herpetological Med Surg 2004;14:1216.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13.

    Garner MM, Hernandez-Divers SM, Raymond JT. Reptile neoplasia: a retrospective study of case submissions to a specialty diagnostic service. Vet Clin North Am Exot Anim Pract 2004;7:653671.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 14.

    Christman J, Devau M, Wilson-Robles H, et al. Oncology of reptiles. Vet Clin North Am Exot Anim Pract 2017;20:87110.

  • 15.

    Gavazza A, Galosi L, Croce V, et al. A case of lymphocytic leukemia in a bearded dragon (Pogona vitticeps) and a review of literature. Acta Vet (Beogr) 2019;69:360368.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16.

    Gilmer L, Reavil D. Chronic lymphocytic leukemia in a bearded dragon (Pogona vitticeps), in Proceedings. ExoticsCon 2018;969.

  • 17.

    Wilson RJ. Incidence of lymphocytosis and lymphoid leukemia in bearded dragons (Pogona vitticeps), in Proceedings. Assoc Reptil Amphib Vet 2013;51.

    • Search Google Scholar
    • Export Citation
  • 18.

    Hahn KA. Chemotherapy dose calculation and administration in exotic animal species. Semin Avian Exotic Pet Med 2005;14:193198.

  • 19.

    Graham JE, Kent MS, Theon A. Current therapies in exotic animal oncology. Vet Clin North Am Exot Anim Pract 2004;7:757781.

  • 20.

    Harrison TM, Kitchell BE. Principles and applications of medical oncology in exotic animals. Vet Clin North Am Exot Anim Pract 2017;20:209234.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 21.

    Zehnder A, Graham J, Antonissen G. Update on cancer treatment in exotics. Vet Clin North Am Exot Anim Pract 2018;21:465509.

  • 22.

    Vail DM, Pinkerton ME, Young KM. Hematopoietic tumors. In: Withrow SJ, Vail DM, Page RL, eds. Small animal clinical oncology. 5th ed. St Louis: Elsevier, 2013;608679.

    • Search Google Scholar
    • Export Citation
  • 23.

    Appelbaum FR. Lo and behold, a role for lomustine in acute myeloid leukemia? Nat Rev Clin Oncol 2010;7:619621.

  • 24.

    Mayer J. Allometric scaling. In: Divers SJ, Scott SJ, eds. Mader's reptile and amphibian medicine and surgery. 3rd ed. St Louis: Elsevier, 2010;11861190.

    • Search Google Scholar
    • Export Citation
  • 25.

    US Pharmacopeia. General chapter 795: pharmaceutical compounding—nonsterile preparations. Available at: www.usp.org/compounding/general-chapter-795. Accessed Mar 30, 2020.

    • Search Google Scholar
    • Export Citation
  • 26.

    Gerson SL, Weeks LD, Chabner BA. Alkylating and methylating agents. In: Chabner BA, Longo DL, eds. Cancer chemotherapy and biotherapy: principles and practice. 6th ed. Alphen aan den Rijn, Netherlands: Wolters Kluwer, 2019;200234

    • Search Google Scholar
    • Export Citation
  • 27.

    Folland DW, Johnston MS, Thamm DH, et al. Diagnosis and management of lymphoma in a green iguana (Iguana iguana). J Am Vet Med Assoc 2011;239:985991.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 28.

    Fournier Q, Serra JC, Handel I, et al. Impact of pretreatment neutrophil count on chemotherapy administration and toxicity in dogs with lymphoma treated with CHOP chemotherapy. J Vet Intern Med 2018;32:384393.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 29.

    Shelton GH, Grant CK, Cotter SM, et al. Feline immunodeficiency virus and feline leukemia virus infections and their relationships to lymphoid malignancies in cats: a retrospective study (1968–1988). J Acquir Immune Defic Syndr 1990;3:623630.

    • Search Google Scholar
    • Export Citation
  • 30.

    Aida Y, Takeshima S, Matsumoto Y, et al. Bovine MHC class II DR molecule plays a key role in bovine leukemia virus (BLV)-induced lymphoma. Retrovirology 2011;8(suppl 1):A7.

    • Crossref
    • Search Google Scholar
    • Export Citation

Advertisement

Lymphoid leukemia in five bearded dragons (Pogona vitticeps)

View More View Less
  • 1 Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27607.

Abstract

CASE DESCRIPTION

2 male and 3 female adult bearded dragons (Pogona vitticeps) were evaluated at the North Carolina State University College of Veterinary Medicine's Exotic Animal Medicine Service between September 2018 and October 2019 because of severe lymphocytosis.

CLINICAL FINDINGS

All 5 bearded dragons had nonspecific clinical signs, including lethargy, poor appetite, ocular discharge, and weight loss. Clinicopathologic testing revealed extremely high lymphocyte counts with morphological findings consistent with lymphocytic leukemia.

TREATMENT AND OUTCOME

All 5 patients were treated with lomustine, prednisolone, and antimicrobials. In addition, 1 or 2 doses of L-asparaginase were administered when the drug was available. Partial remission was achieved in all 5 patients. One patient, after disease progression was documented, was treated with cyclophosphamide and achieved a second partial remission. One of the 5 patients was still alive and continuing to receive chemotherapy at the time of final follow-up 244 days after the initial diagnosis. Survival times (ie, times from initial diagnosis to euthanasia) for the other 4 patients were 57, 157, 330, and 416 days.

CLINICAL RELEVANCE

The present report represented the first description of lomustine as a primary chemotherapeutic agent for the treatment of lymphocytic leukemia in bearded dragons and provided information on response to treatment, adverse effects, and survival times.

Contributor Notes

Address correspondence to Dr. Harrison (tara_harrison@ncsu.edu).